The Procter & Gamble Company Research and Development Expense
The Procter & Gamble Company (PG) reported Research and Development Expense of $2.10 billion for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-04
- The Procter & Gamble Company research and development expense for fiscal 2026 was $2.10B, a 0.00% change from fiscal 2025.
- The Procter & Gamble Company research and development expense for fiscal 2025 was $2.10B, a 5.00% increase from fiscal 2024.
- The Procter & Gamble Company research and development expense for fiscal 2024 was $2.00B, a 0.00% change from fiscal 2023.
- The Procter & Gamble Company research and development expense for fiscal 2023 was $2.00B, a 0.00% change from fiscal 2022.
| Period end | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|
| 2026-06-30 | $2.10B 10-K · filed 2026-08-04 | |
| 2025-06-30 | $2.10B 10-K · filed 2026-08-04 | |
| 2024-06-30 | $2.00B 10-K · filed 2026-08-04 | |
| 2023-06-30 | $2.00B 10-K · filed 2025-08-04 | |
| 2022-06-30 | $2.00B 10-K · filed 2024-08-05 | |
| 2021-06-30 | $1.90B 10-K · filed 2023-08-04 | |
| 2020-06-30 | $1.80B 10-K · filed 2022-08-05 | |
| 2019-06-30 | $1.90B 10-K · filed 2021-08-06 | |
| 2018-06-30 | $1.90B 10-K/A · filed 2020-08-07 | |
| 2017-06-30 | $1.90B 10-K · filed 2019-08-06 | |
| 2016-06-30 | $1.90B 8-K · filed 2018-10-22 | |
| 2015-06-30 | $2.00B 10-K · filed 2017-08-07 | |
| 2014-06-30 | $1.90B 10-K · filed 2016-08-09 | $2.00B 10-K · filed 2014-08-08 |
| 2013-06-30 | $1.90B 8-K · filed 2015-10-26 | $2.00B 10-K · filed 2013-08-08 |
| 2012-06-30 | $2.00B 10-K · filed 2014-08-08 | |
| 2011-06-30 | $2.00B 8-K · filed 2013-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| Longevity Health Holdings, Inc. (XAGE) | United States | $0.006B | -0.09 |